- 商品介绍
- 规格参数
- 包装参数
Application
E17241 may be used to explore its impact on liver steatosis and adipose tissue inflammation in high-fat/high-glucose-fed mice by analyzing histological changes and gene expression profiling; to assess its cardiorenal protective effects in diabetic nephropathy and cardiomyopathy models through tissue morphology and biochemical markers.
Biochem/physiol Actions
E17241 is an orally active pan-PPAR agonist (EC50 in µM = 0.29/γ, 0.88/δ(β), 3.9/α in HepG2 reporter cells) that upregulates PPAR target genes expression (ABCA1 EC50 = 626.9 nM in HepG2 reporter cells). E17241 boosts ABCA1-dependent cholesterol efflux and insulin secretion in INS-1 rat insulinoma cultures (20 nM to 10 µM) and exhibits therapeutic efficacy in diabetic mice in vivo (50 mg/kg via daily p.o.).
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | 2-8°C |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 4390.38
-
¥ 1653.62
-
¥ 2573.97
-
¥ 1196.00
-
¥ 3476.87
-
¥ 2888.88
-
¥ 3662.39
-
询价
-
¥ 165230.53
-
¥ 25008.19
-
¥ 39676.71
-
¥ 51962.23
微信小程序
7X24小时在线咨询